Sorafenib Inhibits Tumor Growth and Improves Survival in a Transgenic Mouse Model of Pancreatic Islet Cell Tumors
Figure 4
Sorafenib prolongs survival in Rip1Tag2 mice. Kaplan-Meier curve and log rank-analysis of Rip1Tag2 mice treated with Sorafenib or mock treatment. Note the significant increased survival in mice treated with Sorafenib ( d versus d; log rank test).